Literature DB >> 30507287

Competition in health markets: is something rotten?

Livio Garattini1, Anna Padula1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30507287      PMCID: PMC6348555          DOI: 10.1177/0141076818816935

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  26 in total

1.  Quasi-market and cost-containment in Beveridge systems: the Lombardy model of Italy.

Authors:  Elenka Brenna
Journal:  Health Policy       Date:  2011-10-24       Impact factor: 2.980

2.  Are health problems systemic? Politics of access and choice under Beveridge and Bismarck systems.

Authors:  Zeynep Or; Chantal Cases; Melanie Lisac; Karsten Vrangbaek; Ulrika Winblad; Gwyn Bevan
Journal:  Health Econ Policy Law       Date:  2010-05-13

3.  Measuring health system performance.

Authors:  P C Smith
Journal:  Eur J Health Econ       Date:  2002

4.  A transaction costs analysis of changing contractual relations in the English NHS.

Authors:  Giorgia Marini; Andrew Street
Journal:  Health Policy       Date:  2006-12-12       Impact factor: 2.980

Review 5.  Five types of OECD healthcare systems: empirical results of a deductive classification.

Authors:  Katharina Böhm; Achim Schmid; Ralf Götze; Claudia Landwehr; Heinz Rothgang
Journal:  Health Policy       Date:  2013-09-13       Impact factor: 2.980

6.  The Americanization of the British National Health Service: A typological approach.

Authors:  Martin Powell; Daniel Béland; Alex Waddan
Journal:  Health Policy       Date:  2018-05-21       Impact factor: 2.980

7.  Could co-payments on drugs help to make EU health care systems less open to political influence?

Authors:  Livio Garattini; Katelijne van de Vooren
Journal:  Eur J Health Econ       Date:  2013-10

Review 8.  Beyond Activity Based Funding. An experiment in Denmark.

Authors:  Viola Burau; Hanne Marlene Dahl; Lotte Groth Jensen; Stina Lou
Journal:  Health Policy       Date:  2018-04-24       Impact factor: 2.980

9.  Private or public hospital ownership: Does it really matter?

Authors:  Afsaneh Bjorvatn
Journal:  Soc Sci Med       Date:  2017-11-21       Impact factor: 4.634

10.  Health Care Spending in the United States and Other High-Income Countries.

Authors:  Irene Papanicolas; Liana R Woskie; Ashish K Jha
Journal:  JAMA       Date:  2018-03-13       Impact factor: 56.272

View more
  9 in total

1.  An era of caution and careful planning.

Authors:  Kamran Abbasi
Journal:  J R Soc Med       Date:  2019-01       Impact factor: 5.344

2.  Defensive medicine in Europe: a 'full circle'?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2019-12-26

3.  Defensive medicine in Europe: a 'full circle'?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2020-06

4.  Conflicts of interest in medicine: a never-ending story.

Authors:  Livio Garattini; Anna Padula; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2020-03-02       Impact factor: 3.397

5.  The Italian NHS at regional level: same in theory, different in practice.

Authors:  Livio Garattini; Marco Badinella Martini; Michele Zanetti
Journal:  Eur J Health Econ       Date:  2021-05-19

6.  Pricing vaccines and drugs in Europe: worth differentiating?

Authors:  Livio Garattini; Anna Padula; Nicholas Freemantle
Journal:  Eur J Health Econ       Date:  2021-12

7.  More room for telemedicine after COVID-19: lessons for primary care?

Authors:  Livio Garattini; Marco Badinella Martini; Michele Zanetti
Journal:  Eur J Health Econ       Date:  2020-11-24

8.  The Italian NHS in Lombardy and Veneto: near but far.

Authors:  Livio Garattini; Marco Badinella Martini; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2021-05-02       Impact factor: 3.397

9.  Improving primary care in Europe beyond COVID-19: from telemedicine to organizational reforms.

Authors:  Livio Garattini; Marco Badinella Martini; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2020-11-16       Impact factor: 3.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.